TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Current Deferred Revenue (2025)

Updated

TFA Therapeutics (RAJAF) posted Current Deferred Revenue of $4,912 for Q4 2025.

Analysis

TFA Therapeutics (RAJAF) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4,912.00
API Access

TFA Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RAJAF&period=max&api_key=YOUR_API_KEY